Israel’s Health Ministry said on Sunday it is examining a small number of cases of heart inflammation in people who had received Pfizer’s COVID-19 vaccine, though it has not yet drawn any conclusions, APA reports quoting Reuters.
Pfizer said it has not observed a higher rate of the condition than would normally be expected in the general population.
Israel's pandemic response coordinator, Nachman Ash, said that a preliminary study showed "tens of incidents" of myocarditis occurring among more than 5 million vaccinated people, primarily after the second dose.
Ash said it was unclear whether this was unusually high and whether it was connected to the vaccine.